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Tuesday, February 23, 2010 435aassembly with the a1-subunit and trafficking to the plasma membrane. The
b2-subunit binds 4-5-fold more efficiently to the ER lectin chaperone, cal-
nexin, and 2-3-fold less efficiently to the non-lectin ER chaperone, BiP,
than the b1-subunit. These results indicate that folding of the b2- and b1-sub-
units is mediated by lectin and non-lectin chaperones, respectively, consistent
with the essential role of N-glycosylation for folding and trafficking of the b2
but not of the b1-subunit. Disruption of the a1-b association by mutations in
defined a1-interacting regions of either b1- or b2-subunits results in the ER
retention of unassembled mutants, indicating that a-b assembly is essential
for the ER export of either b-subunit isoform. In conclusion, the ER quality
control system ensures that only properly folded b-subunits assemble with
the a-subunits and only assembled a-b complexes are exported to the Golgi
and delivered to the plasma membrane.
Supported by NIH, DK077149 and DK58333.
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ATP binding cassette (ABC) transporters constitute a ubiquitous super-family
of integral membrane proteins that translocate a diverse array of substrates
across cell membranes. Studies of several well-characterized systems sug-
gested a mechanistic similarity between different members of this large family
of transporters. However, more recent reports pointed out significant differ-
ences at the genetic and structural levels. We report here a functional compar-
ison between several ABC transporters of different substrate specificities and
find fundamental differences between them. Type I ABC transporters, exempli-
fied by the arch typical maltose transporter, are characterized by an inherent in-
stability of the transporter-receptor complex. In these systems, ATP binding
promotes complex formation, and binding of substrate-loaded receptor acceler-
ates the rate of ATP hydrolysis. In contrast, in type II ABC transporters (the
metal-chelate transporters), the ‘‘default’’ complex is extremely stable. How-
ever, for productive transport to occur, the complex must dissociate, an event
mediated by both substrate and ATP binding. Relative to type I transporters,
high basal ATPase rates are measured with modest to negligible stimulation
by substrate-loaded receptors. These and other findings presented here high-
light significant mechanistic differences between ABC transport systems, indi-
cating that considerable mechanistic diversity exists within this large super-
family of proteins.
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In all organisms, many of the proteins newly synthesized by the ribosome are
targeted to the SecY/Sec61 translocon for secretion or incorporation into the
lipid membrane. Targeting of secreted proteins is generally encoded in a ~20
amino acids extension of the N-terminus of the nascent protein, denoted as the
signal peptide. The translocon opens upon binding of the signal peptide and
the ribosome (or the SecA motor). To understand how SecY/Sec61 opens,
it is essential to know the structure and dynamics of the translocon:signal pep-
tide complex in a hydrated lipid membrane. Molecular dynamics simulations
of the SecY translocon from M. janaaschii with proOmpA signal peptide re-
veal that the structure and dynamics of both the translocon and the signal pep-
tide change significantly upon formation of the complex. It appears that inside
the translocon the signal peptide has a preferred location in which it interacts
with water molecules and with highly conserved SecY amino acids whose
mutation causes translocation defects. Binding of the signal peptide induces
changes in the relative orientation of transmembrane helices of the translocon,
and also affects the structure and interactions with water and the rest of the
protein of the plug segment that closes the periplasmic vestibule of the trans-
locon in the closed state. The structure and dynamics of the translocon and
signal peptide are coupled: mutating the translocon induces changes in the
structure and dynamics not only of the translocon, but also of the signal pep-
tide.
This research was supported in part by the National Institute of General
Medical Sciences (GM-74637 to S.H.W) and the National Science Foundation
(CHE-0750175 to D.J.T.), and an allocation of computer time from the
National Science Foundation through the TeraGrid resources at TACC
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A wide range of peptides is known to
modulate the behavior of lipid mem-
branes, in particular to be able to de-
stabilize the normal lamellar state.
Here we compare the various ways
in which a lipid membrane can be dis-
torted due to the presence of such
peptides, using molecular dynamics
simulations. In particular we show
examples of membrane poration by
antimicrobial peptides, micropinocy-
tosis by cell penetrating peptides,
and the formation of cubic phases
by fusion peptides (see figure).
Snapshot of a single diamond cubic phase induced by the Influenze HA fusion
peptide. The helical parts of the peptides are shown as red rods, the lipid/water
interface as a green surface. Lipid tail beads are shown in gray. This particular
cubic phase is special as it combines both pores (the white gaps) and stalks (filled
with lipid tails) in one phase. The peptides stabilize this stalk/pore structure.
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Cationic liposomes have been used over the past decades with gene therapy or
vaccination trials in mind, considering them primarily as the smart Trojan horse
allowing to go trough the cell walls. Fusion-promoting lipids such asDOPEwere
thus added with some success to try to enhance the destabilizing properties of
some cationic lipids, while others were intrinsically destabilizing. It is difficult
to conceive that lipids that destabilize membranes would act innocently on the
cell physiology. After all, lipids are not only the backbone of membranes, they
also act as facilitators of membrane functions such as endocytosis, budding,
curving; they regulate protein membrane activity and can even serve as signal
transmitters (bioactive lipids). Rather than being considered as responsible for
harmful side-effects that should be minimized, cationic lipids could be consid-
ered as a potential immunostimulating or pharmacological agents. We illustrate
these aspects with diC14-amidine, which forms liposomes with a bilayer at the
edge of instability. DiC14-amidine fuses easily with cell membranes, modifies
cell signaling and activates immune responses through destabilization and/or ac-
tivation of specific membrane receptors, like TLR4 [1,2]. Like it was shown for
natural lipids, this demonstrates that cationic lipids are not only membrane de-
stabilizing agents but might affect cell membrane components function.
1. Lonez C, Vandenbranden M, Ruysschaert JM. Prog Lipid Res. 2008.
47(5):340-7.
2. Tanaka T et al. Eur J Immunol. 2008. 38(5):1351-7.
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Cationic liposomes (CLs) are used as non-viral gene vectors in worldwide
human clinical trials of gene therapy. Because our understanding of the mech-
anisms of action of CL-DNA complexes remains poor and transfection efficien-
cies remain low compared to gene delivery with viral vectors, significant
additional insights and discoveries will be required before the development
of efficient chemical carriers suitable for long-term therapeutic applications.
(For example, virtually all current human gene therapy protocols using lipofec-
tion as a vector contain cholesterol even though very little is understood about
